Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 18;15(12):2001-2008.
doi: 10.18240/ijo.2022.12.16. eCollection 2022.

Fenofibrate for the prevention of progression of non-proliferative diabetic retinopathy: review, consensus recommendations and guidance for clinical practice

Nor Fariza Ngah  1   2 , Nor Asiah Muhamad  3 , Roslin Azni Abdul Aziz  2 , Shelina Oli Mohamed  2 , Nor Azita Ahmad Tarmizi  4 , Azian Adnan  5 , Zalifah Zakiah Asnir  6 , Zanariah Hussein  7 , Hui Foo Siew  5 , Masni Mohamed  7 , Noor Aliza Lodz  8 , Vijayamala Valayatham  6
Affiliations
Review

Fenofibrate for the prevention of progression of non-proliferative diabetic retinopathy: review, consensus recommendations and guidance for clinical practice

Nor Fariza Ngah et al. Int J Ophthalmol. .

Abstract

The prevalence of diabetic retinopathy (DR), and associated morbidity is high in the Asia-Pacific region. Emerging evidence suggests a potential role for fenofibrate in the prevention of progression of DR, especially in patients with cardiovascular risk, and pre-existing mild-to-moderate DR. Fenofibrate has also been found to reduce maculopathy, and the need for laser treatment in these patients. Considering these benefits of fenofibrate, a group of experts from the fields of endocrinology and ophthalmology convened in May 2017, to discuss on the the mechanism of action, and clinical efficacy of fenofibrate in DR. The findings from key clinical studies on fenofibrate in DR were reviewed by the experts, and consensus statements were derived to define the role of fenofibrate in the prevention and treatment of DR. The statements were rated based on the GRADE criteria. An algorithm was also developed for the screening and treatment of DR in patients with type 2 diabetes (T2D), and the place of fenofibrate was defined in the algorithm. The expert recommendations, and the algorithm provided in this review will serve as a guide to the clinicians to reconsider the adjunctive use of fenofibrate for preventing the progression of DR in selected T2D patients.

Keywords: consensus recommendations; diabetic retinopathy; fenofibrate.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Effects of fenofibrate in diabetic retinopathy.
Figure 2
Figure 2. Algorithm for considering patients with T2D for fenofibrate therapy for preventing DR progression
CPG: Clinical practice guidelines; CV: Cardiovascular; T2D: Type 2 diabetes; DR: Diabetic retinopathy.
See this image and copyright information in PMC

References

    1. Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888–e897. - PubMed
    1. Sabanayagam C, Wong TY. Diabetic retinopathy and cardiovascular disease. S. Karger AG. 2019
    1. Hu YD, Teng WP, Liu LM, Chen K, Liu L, Hua R, Chen J, Zhou Y, Chen L. Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning Province, China: a population-based cross-sectional study. PLoS One. 2015;10(3):e0121477. - PMC - PubMed
    1. Raman R, Ganesan S, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care. 2014;2(1):e000005. - PMC - PubMed
    1. Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, Lim SC, Tai ES, Mitchell P. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869–1875. - PubMed

LinkOut - more resources